GlassScriptPhysician profile
Linus T Chuang
NPI 1538100722
$2,739.31
in general payments reported to CMS, 2019-2025
19 companies · $257 in 2025
The $257 reported for 2025 was less than what a typical Gynecologic Oncology provider received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $722 · 2020: $89.20 · 2021: $479 · 2022: $963 · 2024: $229 · 2025: $257.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $486.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $486.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Applied Medical Resources Corporation | $1,181.54 | 2021-2022 | |
| Tesaro, INC. | $411.07 | 2019 | |
| Glaxosmithkline, LLC. | $371.93 | 2019-2025 | Nucala |
| Astrazeneca Pharmaceuticals LP | $155.76 | 2019-2025 | Lynparza |
| Gynesonics, INC. | $102.77 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Genentech USA, INC. | $102.26 | 2019 | |
| Therapeuticsmd, INC. | $79.22 | 2019 | |
| Clovis Oncology, INC. | $61.11 | 2019 | |
| Merck Sharp & Dohme LLC | $51.68 | 2025 | Keytruda |
| Dilon Technologies, INC. | $44.74 | 2025 | Hemoblast Bellows |
| Eisai INC. | $30.20 | 2025 | |
| Davol INC. | $26.53 | 2022 | |
| Coopersurgical, INC. | $26.15 | 2021 | |
| Daiichi Sankyo INC. | $19.43 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $18.05 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $17.99 | 2024 | Libtayo |
| Hologic Sales and Service, LLC | $14.45 | 2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Covidien LP | $12.79 | 2019 | |
| Medtronic, INC. | $11.64 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Linus Chuang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.